GLP-1 Receptor Agonist Analog (SMA designation) is formulated as compressed tablets, 14mg strength, supplied in 30-tablet containers for preclinical bioavailability and oral absorption research. This unique tablet formulation enables investigation of solid-state dosage form development and gastrointestinal absorption kinetics.

Chemical Composition:

• Chemical Name: GLP-1 Receptor Agonist Analog (tablet formulation)
• Molecular Formula: C195H305N51O60S7 (representative structure; active ingredient)
• Molecular Weight: ~4,113 g/mol (active ingredient, approximate)
• Compound Class: GLP-1 receptor agonist; tablet formulation research compound

The compressed tablet format represents a novel delivery platform for peptide research, requiring investigation of formulation stability, tablet disintegration kinetics in simulated gastrointestinal fluids, peptide absorption across intestinal epithelium, and biodegradation protection strategies. Research applications include evaluation of tablet dissolution profiles in pH-varying media (stomach, small intestine), assessment of peptide degradation by proteolytic enzymes during GI transit, investigation of enhanced bioavailability strategies (permeation enhancers, enteric coating), and comparative pharmacokinetics relative to parenteral lyophilized formulations.

Research Applications:

• Tablet dissolution and disintegration testing in USP apparatus per compendial methods
• Peptide stability assessment in simulated gastric and intestinal fluid models
• Intestinal epithelial permeability evaluation using Caco-2 monolayers
• Oral bioavailability and relative bioavailability determination in animal models
• Formulation optimization: excipient compatibility and stability-indicating assay development

Storage and Handling:

• Store tablets at room temperature (15-25°C) in cool, dry conditions
• Keep tablets in original container with desiccant packet to maintain stability
• Protect from light, moisture, and excessive heat exposure
• Do not crush or divide tablets; handle intact for bioavailability studies

Product Specifications:

• Form: Compressed tablets
• Strength: 14mg per tablet
• Quantity: 30 tablets per container
• Purity: >95% (GLP-1 agonist analog content)
• Appearance: White to off-white circular tablets

FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.